ITUB20153058A1 - ?frammento di lattoferrina per uso come agente antibatterico ed antivirale? - Google Patents

?frammento di lattoferrina per uso come agente antibatterico ed antivirale?

Info

Publication number
ITUB20153058A1
ITUB20153058A1 ITUB2015A003058A ITUB20153058A ITUB20153058A1 IT UB20153058 A1 ITUB20153058 A1 IT UB20153058A1 IT UB2015A003058 A ITUB2015A003058 A IT UB2015A003058A IT UB20153058 A ITUB20153058 A IT UB20153058A IT UB20153058 A1 ITUB20153058 A1 IT UB20153058A1
Authority
IT
Italy
Prior art keywords
lattoferrina
antibacterial
fragment
antiviral agent
antiviral
Prior art date
Application number
ITUB2015A003058A
Other languages
English (en)
Inventor
Augusto Sannetti
Francesco Pagano
Stefania Galdiero
Massimiliano GALDIERO
Original Assignee
Farmagens Health Care S R L Roma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmagens Health Care S R L Roma filed Critical Farmagens Health Care S R L Roma
Priority to ITUB2015A003058A priority Critical patent/ITUB20153058A1/it
Priority to PCT/IB2016/054513 priority patent/WO2017025846A1/en
Priority to EP16763573.9A priority patent/EP3334759B1/en
Priority to ES16763573T priority patent/ES2760990T3/es
Publication of ITUB20153058A1 publication Critical patent/ITUB20153058A1/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/79—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
ITUB2015A003058A 2015-08-11 2015-08-11 ?frammento di lattoferrina per uso come agente antibatterico ed antivirale? ITUB20153058A1 (it)

Priority Applications (4)

Application Number Priority Date Filing Date Title
ITUB2015A003058A ITUB20153058A1 (it) 2015-08-11 2015-08-11 ?frammento di lattoferrina per uso come agente antibatterico ed antivirale?
PCT/IB2016/054513 WO2017025846A1 (en) 2015-08-11 2016-07-28 Lactoferrin fragment for the use as antibacterial and antiviral agent
EP16763573.9A EP3334759B1 (en) 2015-08-11 2016-07-28 Lactoferrin fragment for the use as antibacterial and antiviral agent
ES16763573T ES2760990T3 (es) 2015-08-11 2016-07-28 Fragmento de lactoferrina para la utilización como agente antibacteriano y antiviral

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITUB2015A003058A ITUB20153058A1 (it) 2015-08-11 2015-08-11 ?frammento di lattoferrina per uso come agente antibatterico ed antivirale?

Publications (1)

Publication Number Publication Date
ITUB20153058A1 true ITUB20153058A1 (it) 2017-02-11

Family

ID=54843903

Family Applications (1)

Application Number Title Priority Date Filing Date
ITUB2015A003058A ITUB20153058A1 (it) 2015-08-11 2015-08-11 ?frammento di lattoferrina per uso come agente antibatterico ed antivirale?

Country Status (4)

Country Link
EP (1) EP3334759B1 (it)
ES (1) ES2760990T3 (it)
IT (1) ITUB20153058A1 (it)
WO (1) WO2017025846A1 (it)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021191904A1 (en) * 2020-03-26 2021-09-30 Tree Of Life Pharma Ltd. Methods for preventing and treating viral infection

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62249931A (ja) 1986-04-21 1987-10-30 Morinaga Milk Ind Co Ltd 抗菌性組成物
DE69004242T2 (de) 1990-01-23 1994-05-05 Morinaga Milk Industry Co Ltd Laktoferrinhydrolysat zur Verwendung als antibakterielles Mittel.
JP2818056B2 (ja) 1990-09-07 1998-10-30 森永乳業株式会社 抗菌性ペプチドおよび抗菌剤
GB9818938D0 (en) * 1998-08-28 1998-10-21 Alpharma As Bioactive peptides
WO2004089986A1 (en) * 2003-04-14 2004-10-21 Stichting Voor De Technische Wetenschappen Antimicrobial peptide from transferrin family

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
GHOSH ANIRBAN ET AL: "Sequence context induced antimicrobial activity: insight into lipopolysaccharide permeabilization", MOLECULAR BIOSYSTEMS, vol. 10, no. 6, 2014, pages 1596 - 1612, XP002756218 *
MARIEKE I.A VAN DER KRAAN ET AL: "Lactoferrampin: a novel antimicrobial peptide in the N1-domain of bovine lactoferrin", PEPTIDES, 1 January 2004 (2004-01-01), United States, pages 177 - 183, XP055263437, Retrieved from the Internet <URL:http://www.sciencedirect.com/science/article/pii/S0196978103004121/pdfft?md5=23ba10c3fd4822f2b9ad62723ace4f48&pid=1-s2.0-S0196978103004121-main.pdf> [retrieved on 20160406], DOI: 10.1016/j.peptides.2003.12.006 *
RASTOGI NILISHA ET AL: "Preparation and Antimicrobial Action of Three Tryptic Digested Functional Molecules of Bovine Lactoferrin", PLOS ONE, vol. 9, no. 3, March 2014 (2014-03-01), XP002756217 *
VAN DER KRAAN M I A ET AL: "Ultrastructural effects of antimicrobial peptides from bovine lactoferrin on the membranes of Candida albicans and Escherichia coli", PEPTIDES, ELSEVIER, AMSTERDAM, NL, vol. 26, no. 9, 1 September 2005 (2005-09-01), pages 1537 - 1542, XP027856455, ISSN: 0196-9781, [retrieved on 20050901] *

Also Published As

Publication number Publication date
EP3334759A1 (en) 2018-06-20
ES2760990T3 (es) 2020-05-18
WO2017025846A1 (en) 2017-02-16
EP3334759B1 (en) 2019-09-04

Similar Documents

Publication Publication Date Title
HK1256608A1 (zh) 類黃酮組合物及其使用方法
IL285553A (en) Use of prg4 as an anti-inflammatory agent
CL2018000708A1 (es) Fitasas modificadas y métodos de uso
BR112016015706A2 (pt) composto, uso do mesmo e composição farmacêutica
BR112016030968A2 (pt) análogos de pridopidina, preparação e uso destes
BR112016020618A2 (pt) oligômero antissentido, composição farmacêutica, e, uso de um oligômero antissentido
BR112018000129A2 (pt) oxiesteróis e seus métodos de utilização
KR20180084891A (ko) 구조 조성물 및 방법
DK3302292T3 (da) Retraktor
DK3474802T3 (da) Medicinsk forbinding
DK3253485T3 (da) No-holdige sammensætninger
BR112016006614A2 (pt) composições de trichoderma e métodos de uso
DK3296597T3 (da) Krydshovedmotor
DK3373874T4 (da) Medicinsk forbinding
DK3179007T3 (da) Justerbar glasskinnekonstruktion
DK3265057T3 (da) Topisk formulering
BR112017018932A2 (pt) etv2 e usos do mesmo
FR3045729B1 (fr) Biomotors gdi
PL3307275T3 (pl) Postacie użytkowe antybiotyków do wstrzykiwania i ich zastosowanie
ES1137506Y (es) Helice reductora de perdidas
MA43166A (fr) Formulation de fviii
ITUA20163470A1 (it) Formulazione antiappannante
ITUB20153058A1 (it) ?frammento di lattoferrina per uso come agente antibatterico ed antivirale?
TR201503831A2 (tr) Antimipertansif kombinasyon formülasyonları
BR112017016048A2 (pt) método e agente anti-inflamatório